Gastric cancer (GC) cases are predicted to rise by 2040 to approximately 1.8 million cases,
while GC-caused deaths to 1.3 million yearly worldwide. To change this prognosis, there is a …

Simple Summary Gastric cancer with metastasis to the peritoneum carries a poor prognosis,
with a 40% mortality rate. The optimal treatment modalities have not been established for …

Background A model that quantifies the risk of peritoneal recurrence would be a useful tool
for improving decision-making in patients undergoing curative-aim gastrectomy for gastric …

Background The status of the sentinel lymph nodes (SLNs) was an important prognostic
factor in varies cancers. A one-step nucleic acid amplification (OSNA) assay, a molecular …

One-step nucleic acid amplification (OSNA) is a rapid intraoperative molecular detection
technique for sentinel node assessment via the quantitative measurement of target …

Lymphadenectomy represents a fundamental step in the staging and treatment of non-small
cell lung cancer (NSCLC). To date, the extension of lymphadenectomy in early-stage …

Peritoneal dissemination is a common form of gastric cancer (GC) recurrence, despite
surgery with curative intent. This study aimed to evaluate the prognostic value of …

The aim of the study was to compare the prognostic significance of lymph node status of
patients with lung cancer analyzed by three different methods: hematoxylin and eosin (H&E) …

Purpose According to the American Joint Committee on Cancer cancer staging system,
positive peritoneal washing cytology (PWC) indicates stage IV gastric cancer. However …

The presence of peritoneal free cancer cells (FCC) in gastric cancer (GC) patients is a poor
prognostic factor. D2 gastrectomy may induce exfoliated FCC spread from the primary …